Ronald Nahass, MD, Infectious Disease, Hillsborough, NJ, Saint Peter's University Hospital


Infectious Disease Hillsborough, NJ

HIV/AIDS Medicine, Healthcare Associated Infections, Mycobacterial Disease

President-ID CARE, Clinical Professor of Medicine, Rutgers-RW Johnson Medical School

Dr. Nahass is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nahass' full profile

Already have an account?


  • Ronald G. Nahass, MD, FACP, FIDSA, was born and raised in New Jersey. After graduating cum laude from Rensselaer Polytechnic Institute in 1979, he earned his medical degree at the University of Medicine and Dentistry of New Jersey – The Robert Wood Johnson Medical School (RWJMS) in 1982. He completed an internal medicine residency at the Robert Wood Johnson University Hospital (RWJUH) in 1985 and was selected Chief Medical Resident the following year. Dr. Nahass was board certified in Internal Medicine in 1985 and Infectious Diseases in 1988. He received special certification by the American Academy of HIV medicine as an HIV specialist in 2004. He completed the Advanced Special Certification in Hepatitis B in 2006. Dr. Nahass was named the winner of Princeton HealthCare System's 2008 Distinguished Physician Humanitarian Award for his work with patients with AIDS over the last 20 years.

    Dr. Nahass is a Fellow of the American College of Physicians, the Infectious Diseases Society of America, and the Society for Healthcare Epidemiology of America. Dr. Nahass is Chairman of the Quality Committee of the Infectious Diseases Society of America.

    He has been and active member of the Infectious Diseases Society of America having served on the Clinical Affairs Committee, the Value Subcommittee and is currently Chairman of the Quality Committee. He has also earned a master’s degree in Healthcare Management from Harvard University.

    He is a frequent lecturer on HIV, hepatitis, healthcare reform and value of infectious diseases medicine. He is a reviewer for the Archives of Internal Medicine, Clinical Infectious Diseases, and the American Journal of Infection Control. He has published extensively, presented at numerous national meetings and has extensive clinical research experience in viral disease like HIV, HCV, HBV and Herpes as well as infection prevention and patient safety.

Education & Training

  • Harvard University School of Public HealthOTHER_TRAINING
  • UMDNJ-Robert Wood Johnson Medical School
    UMDNJ-Robert Wood Johnson Medical SchoolRESIDENCY
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolMEDICAL_SCHOOL
  • Rensselaer Polytechnic InstituteOTHER_TRAINING

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NJ State Medical License
    NJ State Medical License 1983 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly
  • .Special commendation for self directed learning American Medical Association
  • Distguished Attending Robert Wood Johnson University Hospital
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • Thorn-Induced Alternaria septic arthritis and osteomyelitis of the hand  
    Li Boning, Boretz R, Nahass RG, Infect Dis Clin Practice, 1/1/2016
  • Linkage to Care for Hepatitis C Virus (HCV) Among Suburban Heroin Users in New Jersey  
    Akyar E, Seneca KH, Akyar S, Schoefield N, Schwartz MP, Nahass RG, Emerg Infect Dis, 1/1/2016
  • Implications of baseline HCVRNA level and intrapatient viral load variability on OBV/PTV/R + DSV 12-week treatment outcomes  
    Brown RS, Puoti M, Cooper C, Wyles DL, Sepe TE, Nahass RG, et al, Journal of Hepatology, 1/1/2015
  • Join now to see all


  • C-EDGE CO-STAR: Risk of Reinfection Following Successful Therapy with Elbasvir and Grazoprevir in Persons who Inject Drugs (PWID) Receiving Opioid Agonist Therapy (OAT)
    Dore GJ, Altice F, Litwin AH, Grebely J, Dalgard O, Gane E, Shibolet O, Luetkemeyer A, Nahass R, et al, EASL, Barcelona, Spain, 1/1/2016
  • High efficacy of sofosbuvir/velpatasvir plus gs-9857 for 12 weeks in treatment-experienced genotype 1-6 hcv-infected patients, including those previously treated with ...
    Lawitz E, Kowdley K, Curry M, Reau N, Nguyen M, Kwo P, Jacobson I, Tran T, Nahass RG, EASL, Barcelona, Spain, 1/1/2016
  • Sofosbuvir + PEGInterferon/Ribavirin for 12 weeks vs sofosbuvir + ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experineced cirrhotic ...
    Foster GR, Pianko S, Cooper C, Brown A, Forton D, Nahass RG, et al, EASL, Vienna, Austria, 1/1/2015
  • Join now to see all


  • Infectious Disease Physicians and the Future of Healthcare 
  • HIV/HCV Coinfection 
  • Hepatitits C in Clinical Practice 
    San Diego, CA - 1/1/2015
  • Join now to see all

Press Mentions

  • Press Mention
    Press MentionMay 03, 2017 22:57
  • Press Mention
    Press MentionMay 03, 2017 22:57
  • Press Mention
    Press MentionOctober 30, 2016 10:20
  • Join now to see all

Professional Memberships

Hospital Affiliations